本文へ移動
cccskills
無料GitHub で公開

endo-rtcgm-adip-vs-mdis-smbg-t1d

The skill suggests using real-time continuous glucose monitoring (CGM) combined with algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D) to lower hypoglycemia incidence. Clinical triggers include discussions about insulin pump therapy, CGM use, or reducing hypoglycemia in T1D patients on intensive insulin regimens.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md3.1 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Real-Time Continuous Glucose Monitoring and Algorithm-Driven Insulin Pump vs Multiple Daily Injections with SMBG for Type 1 Diabetes

STEP 1 — Gather Information

Confirm T1D diagnosis, age (adult/child), current insulin regimen (MDI with SMBG ≥3×/day), hypoglycemia history (especially nocturnal/severe), hypoglycemia awareness, patient/family willingness to use devices, insurance/coverage for CGM and pump, baseline HbA1c and time in range, and any contraindications (skin adhesive allergy, device aversion, inability to perform fingersticks).

STEP 2 — Rule In / Rule Out

Is the patient an adult or child with T1D currently on MDI with SMBG ≥3 times daily and seeking to reduce hypoglycemia?

  • Yes → Proceed to Step 3.
  • No → Consider alternative strategies (e.g., maintain current regimen, evaluate other technologies) and stop.

STEP 3 — Classify or Stratify

Stratify by hypoglycemia awareness: presence of impaired awareness of hypoglycemia (IAH) or significant fear of hypoglycemia vs normal awareness; also consider age group (pediatric <18 years vs adult) for device suitability and education needs.

STEP 4 — Decide

If patient has IAH, high hypoglycemia burden, or simply desires reduction, prescribe real-time CGM + algorithm-driven insulin pump; arrange device training, structured education, and plan for periodic SMBG for calibration/validation; set follow-up to review hypoglycemia incidence and glycemic metrics.

Clinical Guardrails / Mimics / Pitfalls

SMBG remains necessary for calibration, sensor warm-up, and confirming discordant symptoms; do not rely solely on CGM for insulin dosing without confirmation. Avoid in patients with severe skin adhesive reactions, inability to manage device alarms, or unwillingness to perform fingersticks. Ensure structured diabetes education is provided. Be aware of cost and insurance barriers; do not use in acute illness where CGM may be inaccurate (e.g., hypotension, vasoconstriction). Do not discontinue SMBG entirely.

Concrete Clinical Example

A 14-year-old adolescent with T1D on MDI 4×/day reports nocturnal hypoglycemia twice weekly and fears sleeping; after confirming eligibility, the clinician prescribes a real-time CGM integrated with an algorithm-driven insulin pump, provides device training, schedules SMBG for calibration, and at 3‑month follow‑up notes reduced nocturnal hypoglycemia and improved time in range.

Source: Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する